TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Influence of a Lifestyle Intervention in Preschool Children on Physiological and Psychological Parameters (Ballabeina)
Brief Summary: Childhood obesity and low fitness tracks into adulthood and carries significant co-morbidities. The investigators test the hypothesis that a multidisciplinary multilevel lifestyle intervention in preschool children in the French and German speaking part of Switzerland during one school-year results in a smaller increase in body mass index (BMI) and a larger increase in aerobic fitness.


Options:
A: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Other: Healthy lifestyle | Arm Label: control group; Type: ACTIVE_COMPARATOR; Interventions: Other: physical activity and dietary guidelines | Intervention Type: OTHER; Name: Healthy lifestyle; Assigned to Arm(s): Intervention group | Intervention Type: OTHER; Name: physical activity and dietary guidelines; Assigned to Arm(s): control group
B: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Intervention group
C: Arm Label: Low Energy Density, Small Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: Low Energy Density, Medium Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: Low Energy Density, Large Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: High Energy Density, Small Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: High Energy Density, Medium Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Arm Label: High Energy Density, Large Portions; Type: EXPERIMENTAL; Interventions: Other: Varying meal energy density and portion size | Intervention Type: OTHER; Name: Varying meal energy density and portion size; Assigned to Arm(s): High Energy Density, Large Portions, High Energy Density, Medium Portions, High Energy Density, Small Portions, Low Energy Density, Large Portions, Low Energy Density, Medium Portions, Low Energy Density, Small Portions
D: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Go NAP SACC | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Go NAP SACC; Assigned to Arm(s): Intervention group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Influence of a Lifestyle Intervention in Preschool Children on Physiological and Psychological Parameters (Ballabeina)
Brief Summary: Childhood obesity and low fitness tracks into adulthood and carries significant co-morbidities. The investigators test the hypothesis that a multidisciplinary multilevel lifestyle intervention in preschool children in the French and German speaking part of Switzerland during one school-year results in a smaller increase in body mass index (BMI) and a larger increase in aerobic fitness.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Intervention group
B: Intervention Type: BEHAVIORAL; Name: Physical activity and diet; Assigned to Arm(s): N/A
C: Arm Label: Nutrition and Physical Activity; Type: EXPERIMENTAL; Interventions: Behavioral: The Food Friends | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: The Food Friends; Assigned to Arm(s): Nutrition and Physical Activity
D: Arm Label: Nutrition and Physical Activity Training; Type: EXPERIMENTAL; Interventions: Behavioral: NAP-SACC Child Care Wellness Program | Arm Label: Delayed Intervention Group; Type: OTHER; Interventions: Behavioral: NAP-SACC Child Care Wellness Program | Intervention Type: BEHAVIORAL; Name: NAP-SACC Child Care Wellness Program; Assigned to Arm(s): Delayed Intervention Group, Nutrition and Physical Activity Training

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Influence of a Lifestyle Intervention in Preschool Children on Physiological and Psychological Parameters (Ballabeina)
Brief Summary: Childhood obesity and low fitness tracks into adulthood and carries significant co-morbidities. The investigators test the hypothesis that a multidisciplinary multilevel lifestyle intervention in preschool children in the French and German speaking part of Switzerland during one school-year results in a smaller increase in body mass index (BMI) and a larger increase in aerobic fitness.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Intervention group
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: ALIVE | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ALIVE; Assigned to Arm(s): Intervention
C: Arm Label: SCORES; Type: EXPERIMENTAL; Interventions: Behavioral: America SCORES, Bay Area | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: America SCORES, Bay Area; Assigned to Arm(s): SCORES
D: Arm Label: Full Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Police Patrolled Walking plus Social Marketing | Arm Label: Walking Only; Type: EXPERIMENTAL; Interventions: Behavioral: Police Patrolled Walking Program Only | Arm Label: General Health; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: General Health Education | Intervention Type: BEHAVIORAL; Name: Police Patrolled Walking plus Social Marketing; Assigned to Arm(s): Full Intervention | Intervention Type: BEHAVIORAL; Name: Police Patrolled Walking Program Only; Assigned to Arm(s): Walking Only | Intervention Type: BEHAVIORAL; Name: General Health Education; Assigned to Arm(s): General Health

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Hydrocortisone and D-Cycloserine on Fear Extinction in Veterans With Posttraumatic Stress Disorder
Brief Summary: This is a research study examining the use of two medications, Hydrocortisone and D-Cycloserine, compared to an inactive substance (placebo), on their ability to reduce fear responses and memory of fear in Veterans with symptoms of Posttraumatic Stress Disorder (PTSD). These responses will be tested using a fear learning and memory task administered by computer.


Options:
A: Arm Label: Control Arm - Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Arm - Propranolol hydrochloride; Type: EXPERIMENTAL; Interventions: Drug: Propranolol Hydrochloride | Intervention Type: DRUG; Name: Propranolol Hydrochloride; Assigned to Arm(s): Intervention Arm - Propranolol hydrochloride
B: Arm Label: Ketamine arm; Type: EXPERIMENTAL; Interventions: Drug: Ketamine | Arm Label: Placebo arm; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ketamine; Assigned to Arm(s): Ketamine arm | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo arm
C: Arm Label: Arm 1: Hydrocortisone; Type: EXPERIMENTAL; Interventions: Drug: Hydrocortisone | Arm Label: Arm 2: D-Cycloserine; Type: EXPERIMENTAL; Interventions: Drug: D-Cycloserine | Arm Label: Arm 3: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Hydrocortisone; Assigned to Arm(s): Arm 1: Hydrocortisone | Intervention Type: DRUG; Name: D-Cycloserine; Assigned to Arm(s): Arm 2: D-Cycloserine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm 3: Placebo
D: Arm Label: Oxepa; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Oxepa (enteral nutrition formula, ABBOTT), at a dose determined by a patient's energy expenditure and tolerance of enteral feeding., Dietary Supplement: oxepa | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Control group | Intervention Type: DIETARY_SUPPLEMENT; Name: Oxepa (enteral nutrition formula, ABBOTT), at a dose determined by a patient's energy expenditure and tolerance of enteral feeding.; Assigned to Arm(s): Oxepa | Intervention Type: DIETARY_SUPPLEMENT; Name: oxepa; Assigned to Arm(s): Oxepa | Intervention Type: DIETARY_SUPPLEMENT; Name: Control group; Assigned to Arm(s): Control group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery
Brief Summary: Prospective, randomized multicenter study to determine the safety and effectiveness of performing corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes with ectasia after refractive surgery.


Options:
A: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Procedure: Corneal collagen | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Procedure: Sham comparator | Intervention Type: PROCEDURE; Name: Corneal collagen; Assigned to Arm(s): Treatment | Intervention Type: PROCEDURE; Name: Sham comparator; Assigned to Arm(s): Control
B: Arm Label: Corneal Collagen Cross-linking (CXL) Treatment Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: riboflavin ophthalmic solution, Device: UVA Irradiation | Arm Label: Control Group; Type: SHAM_COMPARATOR; Interventions: Drug: riboflavin ophthalmic solution | Intervention Type: DRUG; Name: riboflavin ophthalmic solution; Assigned to Arm(s): Control Group, Corneal Collagen Cross-linking (CXL) Treatment Group | Intervention Type: DEVICE; Name: UVA Irradiation; Assigned to Arm(s): Corneal Collagen Cross-linking (CXL) Treatment Group
C: Arm Label: total removal; Type: OTHER; Interventions: Procedure: collagen cross-linking procedure (total removal) | Arm Label: partial removal; Type: OTHER; Interventions: Procedure: collagen cross-linking procedure (partial removal) | Intervention Type: PROCEDURE; Name: collagen cross-linking procedure (total removal); Assigned to Arm(s): total removal | Intervention Type: PROCEDURE; Name: collagen cross-linking procedure (partial removal); Assigned to Arm(s): partial removal
D: Arm Label: Corneal Collagen Cross-linking (CXL) Treatment Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: riboflavin ophthalmic solution, Device: UVA Irradiation | Arm Label: Control Group; Type: SHAM_COMPARATOR; Interventions: Drug: riboflavin ophthalmic solution | Intervention Type: DRUG; Name: riboflavin ophthalmic solution; Assigned to Arm(s): Control Group, Corneal Collagen Cross-linking (CXL) Treatment Group | Intervention Type: DEVICE; Name: UVA Irradiation; Assigned to Arm(s): Corneal Collagen Cross-linking (CXL) Treatment Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II Biomarker Identification Trial for Erlotinib (Tarceva®) in Patients With Advanced Pancreatic Carcinoma
Brief Summary: This study is designed to identify biomarkers which may predict improvement in progression free survival from treatment with Tarceva, in patients with advanced pancreatic cancer who failed one prior regimen of standard chemotherapy or who are deemed unsuitable for chemotherapy. It will also assess the efficacy and safety of Tarceva in this patient population. Patients will be randomized to receive either Tarceva 150mg/day po, or placebo po daily. Tumor tissue will be used for biomarker analysis. The anticipated time on study treatment is until disease progression, and the target sample size is 100-500 individuals.


Options:
A: Arm Label: Gemcitabine; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Gemcitabine plus erlotinib; Type: EXPERIMENTAL; Interventions: Drug: Erlotinib | Intervention Type: DRUG; Name: Erlotinib; Assigned to Arm(s): Gemcitabine plus erlotinib
B: Arm Label: Gemcitabine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Gemcitabine | Arm Label: Axitinib [AG-013736] plus gemcitabine; Type: EXPERIMENTAL; Interventions: Drug: AG-013736, Drug: Gemcitabine | Intervention Type: DRUG; Name: Gemcitabine; Assigned to Arm(s): Gemcitabine | Intervention Type: DRUG; Name: AG-013736; Assigned to Arm(s): Axitinib [AG-013736] plus gemcitabine | Intervention Type: DRUG; Name: Gemcitabine; Assigned to Arm(s): Axitinib [AG-013736] plus gemcitabine
C: Arm Label: Erlotinib; Type: EXPERIMENTAL; Interventions: Drug: Erlotinib | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Erlotinib; Assigned to Arm(s): Erlotinib | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: cetuximab + bevacizumab + gemcitabine; Type: EXPERIMENTAL; Interventions: Biological: cetuximab, Biological: bevacizumab, Drug: gemcitabine | Arm Label: cetuximab + bevacizumab; Type: ACTIVE_COMPARATOR; Interventions: Biological: cetuximab, Biological: bevacizumab | Intervention Type: BIOLOGICAL; Name: cetuximab; Assigned to Arm(s): cetuximab + bevacizumab, cetuximab + bevacizumab + gemcitabine | Intervention Type: BIOLOGICAL; Name: bevacizumab; Assigned to Arm(s): cetuximab + bevacizumab, cetuximab + bevacizumab + gemcitabine | Intervention Type: DRUG; Name: gemcitabine; Assigned to Arm(s): cetuximab + bevacizumab + gemcitabine | Intervention Type: BIOLOGICAL; Name: cetuximab; Assigned to Arm(s): cetuximab + bevacizumab, cetuximab + bevacizumab + gemcitabine

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Clinical Study to Evaluate the Use of Episodic, Intensive Blood Glucose Monitoring in Persons With Non-insulin Treated Type 2 Diabetes
Brief Summary: This randomized, parallel group study will determine whether the use of episodic, intensive glucose monitoring via the Accu-Chek 360 view blood glucose analysis system has a positive effect on overall glycemic control. Patients will be randomized into either the 'usual care' group, or the 'interventional group' supplemented with the Accu-Chek 360 view blood glucose analysis system. The effect of each treatment regimen on glycemic control will be assessed by measurement of change in baseline HbA1c values at 12 months. The anticipated time on study treatment is 1 year, and the target sample size is 504 individuals.


Options:
A: Arm Label: LIVE Arm; Type: EXPERIMENTAL; Interventions: Behavioral: LIVE | Arm Label: Website; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Website | Intervention Type: BEHAVIORAL; Name: LIVE; Assigned to Arm(s): LIVE Arm | Intervention Type: BEHAVIORAL; Name: Website; Assigned to Arm(s): Website
B: Arm Label: Active Control Group (ACG); Type: OTHER; Interventions: Device: Accu-Chek Aviva Glucose Meter | Arm Label: Structured Testing Group (STG); Type: EXPERIMENTAL; Interventions: Device: Accu-Chek 360° View Blood Glucose Analysis Tool, Device: Accu-Chek Aviva Glucose Meter | Intervention Type: DEVICE; Name: Accu-Chek 360° View Blood Glucose Analysis Tool; Assigned to Arm(s): Structured Testing Group (STG) | Intervention Type: DEVICE; Name: Accu-Chek Aviva Glucose Meter; Assigned to Arm(s): Active Control Group (ACG), Structured Testing Group (STG)
C: Intervention Type: BEHAVIORAL; Name: An individual motivational intervention program to promote and maintain self-care behaviour; Assigned to Arm(s): N/A
D: Arm Label: 1 (Couples); Type: EXPERIMENTAL; Interventions: Behavioral: Telephone support and behavior change | Arm Label: 2 (Individual); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Telephone support and behavior change | Arm Label: 3 (Control); Type: PLACEBO_COMPARATOR; Interventions: Other: Diabetes self-management education | Intervention Type: BEHAVIORAL; Name: Telephone support and behavior change; Assigned to Arm(s): 1 (Couples), 2 (Individual) | Intervention Type: OTHER; Name: Diabetes self-management education; Assigned to Arm(s): 3 (Control)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial for Repetitive Deliberate Self-harm and Suicidal Behaviours Among Norwegian Adolescents: a Comparison Between Dialectical Behaviour Therapy Adapted for Adolescents (DBT-A) and Enhanced Usual Care (EUC)
Brief Summary: The purpose of the study is to evaluate the efficiency of dialectical behavior therapy (DBT) in treatment of adolescents with deliberate self harm compared to Enhanced Usual Care (EUC). Eighty patients in the age of 12-18 yrs old will be included in the study. The main inclusion criterion is repetitive deliberate self-harm. The patients will receive 16 weeks treatment in outpatient clinics in Oslo, after having been randomized to DBT or EUC. They will be assessed on five different time-points: baseline (before starting treatment), 6 weeks (after start of treatment), 12 weeks, 16 weeks and 68 weeks.

The main study hypothesis is:

* DBT will be significantly more effective in treatment of self-harm behavior, as measured/indicated by reduction in number of self-harm episodes with or without intent to die, as well as reduction of number of emergency room visits.
* It is also hypothesized that DBT will significantly reduce the level of suicidal ideation and depressive symptoms compared to EUC.


Options:
A: Arm Label: Brief Cognitive Behavioral Therapy (BCBT); Type: EXPERIMENTAL; Interventions: Behavioral: Brief Cognitive Behavioral Therapy (BCBT) | Arm Label: Treatment As Usual (TAU); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment As Usual (TAU) | Intervention Type: BEHAVIORAL; Name: Brief Cognitive Behavioral Therapy (BCBT); Assigned to Arm(s): Brief Cognitive Behavioral Therapy (BCBT) | Intervention Type: BEHAVIORAL; Name: Treatment As Usual (TAU); Assigned to Arm(s): Treatment As Usual (TAU)
B: Arm Label: Control (volitional help sheet); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Volitional help sheet | Arm Label: Intervention (volitional help sheet); Type: EXPERIMENTAL; Interventions: Behavioral: Volitional help sheet | Intervention Type: BEHAVIORAL; Name: Volitional help sheet; Assigned to Arm(s): Control (volitional help sheet) | Intervention Type: BEHAVIORAL; Name: Volitional help sheet; Assigned to Arm(s): Intervention (volitional help sheet)
C: Arm Label: Dialectical Behavior Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical Behaviour Therapy | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dialectical Behaviour Therapy; Assigned to Arm(s): Dialectical Behavior Therapy
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical behavioral therapy for adolescents (DBT-A) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Intervention Type: BEHAVIORAL; Name: Dialectical behavioral therapy for adolescents (DBT-A); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial for Repetitive Deliberate Self-harm and Suicidal Behaviours Among Norwegian Adolescents: a Comparison Between Dialectical Behaviour Therapy Adapted for Adolescents (DBT-A) and Enhanced Usual Care (EUC)
Brief Summary: The purpose of the study is to evaluate the efficiency of dialectical behavior therapy (DBT) in treatment of adolescents with deliberate self harm compared to Enhanced Usual Care (EUC). Eighty patients in the age of 12-18 yrs old will be included in the study. The main inclusion criterion is repetitive deliberate self-harm. The patients will receive 16 weeks treatment in outpatient clinics in Oslo, after having been randomized to DBT or EUC. They will be assessed on five different time-points: baseline (before starting treatment), 6 weeks (after start of treatment), 12 weeks, 16 weeks and 68 weeks.

The main study hypothesis is:

* DBT will be significantly more effective in treatment of self-harm behavior, as measured/indicated by reduction in number of self-harm episodes with or without intent to die, as well as reduction of number of emergency room visits.
* It is also hypothesized that DBT will significantly reduce the level of suicidal ideation and depressive symptoms compared to EUC.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical behavioral therapy for adolescents (DBT-A) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as usual | Intervention Type: BEHAVIORAL; Name: Dialectical behavioral therapy for adolescents (DBT-A); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): 2
B: Arm Label: Control group; Type: OTHER; Interventions: Behavioral: Relaxation | Arm Label: Therapy ACT; Type: EXPERIMENTAL; Interventions: Behavioral: ACT therapy | Intervention Type: BEHAVIORAL; Name: Relaxation; Assigned to Arm(s): Control group | Intervention Type: BEHAVIORAL; Name: ACT therapy; Assigned to Arm(s): Therapy ACT
C: Arm Label: Diaclectical Behavioral Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Therapy | Arm Label: Support Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Therapy | Arm Label: Controls; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Behavioral Therapy; Assigned to Arm(s): Diaclectical Behavioral Therapy, Support Therapy
D: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: APSOM vs Control | Arm Label: APSOM; Type: OTHER; Interventions: Other: APSOM vs Control | Intervention Type: OTHER; Name: APSOM vs Control; Assigned to Arm(s): APSOM, Control

Answer: A